EK - Local recommendations (Eye)
Use documents past their review date with caution
Glaucoma and ocular hypertension
| Recommendation | Approval date | Review date |
| Monopost preservative free eye drops | August 2013 | April 2021 |
| Bimatoprost Eye Drops 300mcg discontinuation, EKPG | October 2015 | April 2021 |
Retinal disorders
| Recommendation | Approval date | Review date |
| PR 2017-12 Verteporfin with PDT for CSCR - EKPG Recommendation | November 2017 | November 2020 |
Dry eye lubricants
| Recommendation | Approval date | Review date |
| KM ICB Dry Eye Guidance | February 2024 | February 2026 |
Minor Eye Conditions Service (MECS) Formulary
| Recommendation | Approval date | Review date |
| MECS formulary | November 2018 | November 2020 |
Allergic and Inflammatory Conditions (Eye)
| Recommendation | Approval date | Review date |
| Allergic Rhinoconjunctivitis Treatment Pathway for Children (<16 years of age) | February 2025 | February 2027 |
| Allergic Rhinoconjunctivitis Treatment Pathway for ADULTS | April 2025 | April 2027 |
General (Eye)
| Recommendation | Approval date | Review date |
| Ophthalmology guidance for Eye Drops Prescriptions | May 2015 | April 2021 |
| Nutritional Supplementation and AMD - EKPG | June 2014 | April 2021 |
| Ciclosporin eye drops 0.1% | May 2016 | April 2021 |
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary